Mark Lawler
Prof Mark Lawler is an internationally recognized cancer research expert affiliated with Queen’s University Belfast. He has made significant contributions to understanding the relationship between obesity and cancer, advocating for innovative approaches in cancer prevention. Recently, he commented on a landmark study suggesting that GLP-1 receptor agonists could nearly halve the risk of obesity-related cancers, calling the findings transformational for preventive cancer medicine.
Not in the pool (under ¢1).
Recent news mentions
Mark Lawler, a professor of digital health at Queen’s University Belfast, co-authored the report highlighting the cancer workforce crisis.
World faces cancer workforce crisis with 100m staff shortfall, report warns | Cancer
United Kingdom· 2026-05-31
Mark Lawler is an internationally recognized cancer researcher who believes that the results could lead to breakthroughs in reducing cancer risk.
Index - Tudomány - Áttörés jöhet a rákmegelőzésben, ez jelentheti a megoldás kulcsát
Hungary· 2025-05-16
Prof Mark Lawler is an internationally renowned cancer research expert who commented on the study's findings.
Weight-loss jabs could halve risk of obesity-related cancers, study finds | ObesityUnited Kingdom· 2025-05-12